|
Market Closed -
TEL AVIV STOCK EXCHANGE
11:30:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 2,450.00 ILa | -0.04% |
|
+1.37% | +8.41% |
| 10-06 | Kamada Launches Ustekinumab, Enoxaparin Biosimilars in Israel | MT |
| 10-06 | Kamada Ltd. Announces Expansion of Biosimilars Portfolio with Launch of Two Additional Products in Israel | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| KAMADA LTD. | Biopharmaceuticals | -0.04% | +1.37% | +8.41% | +7.83% | +36.95% | 453M |  |  |  |
- Stock Market
- Stocks
- KMDA Stock
- Charts Kamada Ltd.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
